Viewing Study NCT02819635


Ignite Creation Date: 2025-12-24 @ 10:07 PM
Ignite Modification Date: 2026-02-24 @ 3:16 PM
Study NCT ID: NCT02819635
Status: COMPLETED
Last Update Posted: 2022-06-30
First Post: 2016-06-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ulcerative Colitis (UC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Upadacitinib (ABT-494) View
None Moderately to Severely Active UC View
None RINVOQ View